David Turkaly
Stock Analyst at JMP Securities
(2.13)
# 2,961
Out of 5,033 analysts
140
Total ratings
39.06%
Success rate
-4.49%
Average return
Main Sectors:
Stocks Rated by David Turkaly
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KIDS OrthoPediatrics | Maintains: Market Outperform | $35 → $25 | $17.24 | +45.01% | 12 | Oct 10, 2025 | |
| LNTH Lantheus Holdings | Maintains: Market Outperform | $112 → $73 | $55.60 | +31.29% | 9 | Aug 7, 2025 | |
| OFIX Orthofix Medical | Reiterates: Market Perform | n/a | $15.07 | - | 2 | Jun 6, 2025 | |
| GMED Globus Medical | Reiterates: Market Perform | n/a | $59.58 | - | 3 | May 27, 2025 | |
| HAE Haemonetics | Reiterates: Market Outperform | $100 | $50.26 | +98.97% | 12 | May 20, 2025 | |
| STE STERIS | Maintains: Market Outperform | $265 → $280 | $240.21 | +16.56% | 18 | May 16, 2025 | |
| IART Integra LifeSciences Holdings | Maintains: Market Outperform | $35 → $25 | $15.08 | +65.78% | 15 | May 9, 2025 | |
| ENOV Enovis | Maintains: Market Outperform | $62 → $55 | $31.42 | +75.05% | 2 | May 9, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Market Outperform | $140 → $125 | $101.92 | +22.65% | 14 | May 7, 2025 | |
| CRWD CrowdStrike Holdings | Maintains: Market Outperform | $400 → $500 | $484.65 | +3.17% | 1 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $374.42 | - | 3 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $128.13 | - | 15 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $12 → $7 | $1.53 | +357.52% | 6 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $26 | $16.59 | +56.72% | 7 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $32 | $14.74 | +117.10% | 7 | Feb 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $16 | $7.65 | +109.15% | 1 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $2.92 | - | 5 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $7 → $3 | $2.69 | +11.52% | 7 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $5 | $7.95 | -37.11% | 1 | Oct 6, 2017 |
OrthoPediatrics
Oct 10, 2025
Maintains: Market Outperform
Price Target: $35 → $25
Current: $17.24
Upside: +45.01%
Lantheus Holdings
Aug 7, 2025
Maintains: Market Outperform
Price Target: $112 → $73
Current: $55.60
Upside: +31.29%
Orthofix Medical
Jun 6, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $15.07
Upside: -
Globus Medical
May 27, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $59.58
Upside: -
Haemonetics
May 20, 2025
Reiterates: Market Outperform
Price Target: $100
Current: $50.26
Upside: +98.97%
STERIS
May 16, 2025
Maintains: Market Outperform
Price Target: $265 → $280
Current: $240.21
Upside: +16.56%
Integra LifeSciences Holdings
May 9, 2025
Maintains: Market Outperform
Price Target: $35 → $25
Current: $15.08
Upside: +65.78%
Enovis
May 9, 2025
Maintains: Market Outperform
Price Target: $62 → $55
Current: $31.42
Upside: +75.05%
Zimmer Biomet Holdings
May 7, 2025
Maintains: Market Outperform
Price Target: $140 → $125
Current: $101.92
Upside: +22.65%
CrowdStrike Holdings
May 5, 2025
Maintains: Market Outperform
Price Target: $400 → $500
Current: $484.65
Upside: +3.17%
May 5, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $374.42
Upside: -
Apr 2, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $128.13
Upside: -
Mar 21, 2025
Maintains: Market Outperform
Price Target: $12 → $7
Current: $1.53
Upside: +357.52%
Mar 5, 2025
Reiterates: Market Outperform
Price Target: $26
Current: $16.59
Upside: +56.72%
Feb 25, 2025
Reiterates: Market Outperform
Price Target: $32
Current: $14.74
Upside: +117.10%
Jan 29, 2025
Reiterates: Market Outperform
Price Target: $16
Current: $7.65
Upside: +109.15%
Sep 16, 2024
Reiterates: Market Perform
Price Target: n/a
Current: $2.92
Upside: -
Aug 14, 2024
Maintains: Market Outperform
Price Target: $7 → $3
Current: $2.69
Upside: +11.52%
Oct 6, 2017
Initiates: Outperform
Price Target: $5
Current: $7.95
Upside: -37.11%